Veracyte (NASDAQ: VCYT) reported Q4 EPS of ($0.36), $0.03 worse than the analyst estimate of ($0.33). Revenue for the quarter came in at $12.2 million versus the consensus estimate of $11.83 million.

Veracyte sees FY2015 revenue of $48-53 million, versus the consensus of $59.1 million.

For earnings history and earnings-related data on Veracyte (VCYT) click here.